BlackRock Investment Management, LLC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 71 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q4 2016$986,000
-25.9%
56,235
+0.6%
0.00%
-50.0%
Q3 2016$1,330,000
+57.6%
55,913
+6.0%
0.00%
+100.0%
Q2 2016$844,000
-17.5%
52,724
+7.8%
0.00%0.0%
Q1 2016$1,023,000
-20.6%
48,920
+2.5%
0.00%
-50.0%
Q4 2015$1,289,000
-2.3%
47,750
+0.6%
0.00%0.0%
Q3 2015$1,319,000
+33.0%
47,469
+17.2%
0.00%
+100.0%
Q2 2015$992,000
+2581.1%
40,486
+1886.6%
0.00%
Q1 2015$37,0000.0%2,038
+2.5%
0.00%
Q4 2014$37,000
+85.0%
1,988
-5.0%
0.00%
Q3 2014$20,000
+122.2%
2,093
+103.4%
0.00%
Q2 2014$9,0001,0290.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q1 2016
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders